Answers from the Lab

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, discuss summertime illnesses and key insights from a recent diagnostic investment event. Together, they explore: Common summertime illnesses, along with tips for prevention.  How invest...

Linda Hasadsri, M.D., Ph. D., and Huong Cabral, M.S., CGC, explain how Mayo Clinic Laboratories' expanded test panel captures rarer as well as more common genetic causes of hereditary pancreatitis. That information is key to managing patients' enhanced risk for pancreatic cancer. (00:32)  Could you both please tell us a little bit about yourself and your background?   (02:23)  Could you please giv...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, share insights from industry news and recent conferences, including PlatforMed . They explore: The significant interest in diagnostics for the advancement of cancer care. The Joint Comm...

Joshua Bornhorst, Ph. D., explains how Mayo Clinic Laboratories' labile copper assay ( Mayo ID: LBCS ) improves upon standard blood tests for Wilson's disease. The new test measures not just overall copper but also the fraction of copper that is bioavailable, or labile bound. (00:32) Can you tell us a little bit about yourself and your background?   (01:33)  Could you give us a brief overview of t...

John Lieske, M.D., and Sandra Taler, M.D., explain how Mayo Clinic Laboratories' mass spectrometry assay helps evaluate patients for resistant hypertension. The test detects antihypertensive medications in urine, providing evidence of whether patients are absorbing their medications or whether a new treatment approach might be needed.  Speaker 3: (00:33)  Could you tell us a little about yourselve...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Div Dubey, M.B.B.S. , a neurologist and co-director of the Clinical Neuroimmunology Laboratory at Mayo Clinic, explore the topic of peripheral neuropathy. Their discussion covers: The high prevalence of peripheral neuropathy and why early diagnosis is important.  Th...

Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay ( Mayo ID: ADVQU ) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children. (01:14) Could you give us a brief overview of this assay?   (02:06) Can you explain the differences of...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, discuss global trends in diagnostic manufacturing and their implications for laboratory professionals. Topics include:  Emerging innovations in mass spectrometry, next-generation sequen...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss the value laboratories deliver for their entire health system. They cover how laboratories impact: Growth in revenue Growth in lab charges Growth in ancillary servic...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss tick-borne diseases. They cover: Different diseases patients can get from ticks.  Disease prevention, including Dr. Pritt’s A through Z flash cards with tips for peo...

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, is joined by Russ Lebovitz, M.D., Ph. D., CEO and co-founder of Amprion . They discuss their strategic collaboration and the innovative SAAmplify™–αSYN (CSF) test. They covered:  Details about how the cerebrospinal fluid biomarker test ( Mayo ID: ASYNC ) benefits patients exh...

Paul Jannetto, Ph. D., explains how Mayo Clinic Laboratories' SPAS test identifies the form of arsenic present in patients with arsenic exposure. That information is important for determining the potential level of harm and for removing the patient from the arsenic source to ease symptoms and prevent cancer risk. (00:33) Do you mind telling us a little bit about yourself and your background?   (01...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss the recent court judgment on the U.S. Food and Drug Administration’s (FDA) oversight of lab-developed tests (LDT). They covered:    Details about the ruling to vacat...

Jessica Wright, Pharm. D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after non-liver organ transplants. Optimal tacrolimus levels are one of the important factors in survival of the transplanted organ. (00:32) Could you provide us a with little bit about your background and yourself?   (03:45) Will you please provide a brief ov...

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, invited Min-Han Tan, M.B.B.S., FRCP, Ph. D., founding CEO and medical director of Lucence , to discuss liquid biopsy cancer testing . Mayo Clinic Laboratories and Lucence recently announced a collaboration to expand access to this cutting-edge cancer test that is designed to...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss the evolution of retail health. They cover several key topics, including: The emergence of retail health locations. Three types of care that are well-suited for a re...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss infectious disease activity around the nation. They cover:     The high prevalence of influenza A, avian influenza, measles, and COVID-19.  Reliable resources for in...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph. D. , director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a conversation about innovation in testing for sexually transmitted infections (STI). Topics include:  The advantages and challenges of new types of specimen...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, for a conversation about quality management. Specifically, they discuss:  The benefit of investing in quality management for patients, staff, and the organization. How Mayo Cli...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories.  They discuss recent business trends in diagnostics and why it is important for pathologists to stay informed about these trends. Their conversation covers:  What’s driving a r...

Sanjeev Sethi, M.D., Ph. D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal management of this serious kidney disease. (00:32) Would you mind telling us a little bit about yourself and your background?   (01:58) Would you give us an over...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories.  They discuss Dr. Morice’s recent article in Becker’s Hospital Review, “ Nine Developments Predicted to Shape Laboratory Medicine and Diagnostics in 2025 ,” and go deeper into...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Erin Graf, Ph. D., co-director of Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Arizona, to discuss benefits of automation in the laboratory.    Topics of discussion include: Specific examples of how they are using au...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss emerging concerns about H5N1 avian influenza.  Specific topics of discussion include: Patterns of transmission and what they indicate about the potential of person-t...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D. , CEO and president of Mayo Clinic Laboratories, to discuss the progress of artificial intelligence (AI) and what’s next in this space. Specific topics of discussion include: What’s driving the rapid acceleration of AI advanc...